We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

101 hedge funds and large institutions have $197M invested in Fulcrum Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more call options, than puts

Call options by funds: $4.55M | Put options by funds: $350K

82% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 22

0.8% more ownership

Funds ownership: 97.13% → 97.93% (+0.8%)

6% less funds holding

Funds holding: 108 → 101 (-7)

24% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 25

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

79% less capital invested

Capital invested by funds: $918M → $197M (-$721M)

Holders
101
Holders Change
-7
Holders Change %
-6.48%
% of All Funds
1.7%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
19
Increased
40
Reduced
22
Closed
25
Calls
$4.55M
Puts
$350K
Net Calls
+$4.2M
Net Calls Change
-$123K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$16.3M
2
LGM
Logos Global Management
California
+$9.28M
3
SCM
Suvretta Capital Management
New York
+$7.25M
4
BlackRock
BlackRock
New York
+$4.16M
5
DTC
Deep Track Capital
Connecticut
+$3.42M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$16.4M
2
CAC
Cowen and Company
New York
-$10.4M
3
MIM
Monashee Investment Management
Massachusetts
-$5.6M
4
SI
Sofinnova Investments
California
-$5.43M
5
PBA
Paradigm Biocapital Advisors
New York
-$5.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$1.24M +$2.37M +242,167 +2,224%
Two Sigma Investments
27
Two Sigma Investments
New York
$1.05M +$1.93M +197,863 +1,171%
ACP
28
Acuta Capital Partners
California
$980K – – –
JP Morgan Chase
29
JP Morgan Chase
New York
$971K -$22.2K -2,271 -1%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$683K -$3.99M -407,922 -75%
FT
31
Fiduciary Trust
Massachusetts
$649K – – –
Man Group
32
Man Group
United Kingdom
$612K – – –
Two Sigma Advisers
33
Two Sigma Advisers
New York
$545K +$252K +25,800 +30%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$512K +$36.9K +3,781 +4%
Bank of America
35
Bank of America
North Carolina
$508K +$868K +88,836 +599%
Charles Schwab
36
Charles Schwab
California
$422K +$134K +13,710 +19%
Millennium Management
37
Millennium Management
New York
$398K +$793K +81,197 New
Renaissance Technologies
38
Renaissance Technologies
New York
$333K +$665K +68,000 New
Swiss National Bank
39
Swiss National Bank
Switzerland
$306K – – –
TCM
40
Tekla Capital Management
Massachusetts
$287K -$183K -18,756 -24%
Citadel Advisors
41
Citadel Advisors
Florida
$275K -$549K -56,156 -50%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$233K +$131K +13,412 +39%
IBT
43
International Biotechnology Trust
United Kingdom
$194K -$799K -81,792 -99%
Jane Street
44
Jane Street
New York
$186K +$224K +22,972 +154%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$180K +$20.1K +2,059 +6%
AllianceBernstein
46
AllianceBernstein
Tennessee
$164K +$116K +11,900 +55%
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
$156K +$311K +31,813 New
OQS
48
Occudo Quantitative Strategies
Florida
$154K +$307K +31,438 New
Squarepoint
49
Squarepoint
New York
$152K +$5.54K +567 +2%
SSA
50
Schonfeld Strategic Advisors
New York
$150K -$88K -9,000 -23%
1
2
3 4 5

FULC Hedge Fund Activity: Q2 2022 in Review

101 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q2 2022, worth a combined $197M — down 79% from $918M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of FULC and 19 opened new positions — a net loss of 6 holders — while 22 trimmed existing stakes and 40 added.

The largest buyer was Point72 Asset Management, adding an estimated $16.3M. The largest seller was Adage Capital Partners, cutting an estimated $16.4M.

  • 101 institutional investors held Fulcrum Therapeutics (FULC) as of Q2 2022, down from 108 in Q1 2022.
  • Funds reported $197M of Fulcrum Therapeutics stock for Q2 2022, down 79% quarter-over-quarter.
  • 19 funds opened new Fulcrum Therapeutics positions in Q2 2022 and 25 closed out, a net change of -6 holders.
  • The largest Fulcrum Therapeutics buyer in Q2 2022 was Point72 Asset Management, an estimated $16.3M added.
  • The largest Fulcrum Therapeutics seller in Q2 2022 was Adage Capital Partners, an estimated $16.4M sold.

Based on aggregated 13F filings for Q2 2022.